Posted on April 18, 2017 | By Brittany Johnson
April 19, 2017 – Wolters Kluwer recently announced the release of new workflow enhancements within its Pharmacy OneSource Sentri7® clinical surveillance solution. The new offering is designed to help pharmacists manage their daily workloads within increasingly complex and demanding healthcare environments.
In tandem with industry trends across most hospital departments, pharmacies face increased pressure to increase quality of care while reducing costs within evolving value-based care delivery models. New features within Sentri7 further streamline workflows by providing an at-a-glance look at the number of patients qualifying for clinical initiatives, helping users balance patient priorities across departments and specialties. They also provide better tools for managing the continuum of patient care over multiple days and between shift changes.
Sentri7 drives continuous improvement by leveraging EMR investments to empower clinicians to operate smarter and more efficiently. An interoperable SaaS platform, the HIPAA-compliant clinical decision support surveillance solution provides real-time aggregation of patient data to automate tracking, identification and reporting of patient issues to enable proactive governance and management of critical clinical initiatives. Sentri7 clinical content is created and maintained by clinicians and put through a rigorous editorial process that synthesizes the most up-to-date medical information into accurate, trusted, evidence-based alerts and care recommendations designed to achieve important clinical outcomes.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
# # #
Marketing Director, Pharmacy OneSource
Wolters Kluwer | Clinical Software Solutions
(425) 451-4063 ext.199
Written for clinicians